CG Oncology, Inc. rose 14.0% on Monday, November 16, 2026, on 9,881,332 shares, 9.9 times its average daily volume. Headlines around the move:
CG Oncology, Inc. (CGON:NASDAQ) closed at $84.78 on November 16, 2026, up 13.95% on the day. The stock trades 9.8% below its 52-week high of $93.95 and 129.1% above its 52-week low of $37.01. Over the past year, it gained 99.2%. CG Oncology, Inc. is part of the Health Care sector.
In 252 trading sessions since November 14, 2025, CGON closed higher on 126 days (50%). Its best day was January 9, 2026 (+29.26%) and its worst was October 6, 2026 (-7.38%). The stock moved 10% or more in a single session 4 times. It opened at least 5% above the previous day's high 1 time.
CG Oncology is a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients afflicted with bladder cancer. We see a world where urologic cancer patients can benefit from our innovative immunotherapies to live with dignity and have an enhanced quality of life.
Find more stocks like CGON with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.